OVX836
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OVX836, covering 2022-09-22 to 2025-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836 [Phase 2]